NCT03653117View on ClinicalTrials.gov

Transperineal Laser Ablation for Treatment of Benign Prostatic Obstruction

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 18, 2018

Primary Completion Date

May 23, 2022

Study Completion Date

May 23, 2022

Conditions
Prostatic Hyperplasia, Benign
Interventions
DEVICE

Transperineal laser ablation

Minimal invasive coagulation of prostatic tissue by laser

Trial Locations (1)

1105AZ

Academic Medical Center, Amsterdam

All Listed Sponsors
collaborator

Elesta S.R.L.

INDUSTRY

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT03653117 - Transperineal Laser Ablation for Treatment of Benign Prostatic Obstruction | Biotech Hunter | Biotech Hunter